Table 2 Cycle characteristics and ART outcomes.

From: Serum levels of anti-Müllerian hormone influence pregnancy outcomes associated with gonadotropin-releasing hormone antagonist treatment: a retrospective cohort study

 

Group A (AMH = 1.1–4.0 ng/ml)

Group B (AMH > 4.0 ng/ml)

p value

Retrieved oocytes(n)

9.83 ± 5.31

16.40 ± 8.12

 < 0.001

MII oocytes(n)

8.48 ± 4.84

14.04 ± 7.44

 < 0.001

Fresh embryo transfer(n)

259

160

 

CPR

44.79%(116/259)

48.13%(77/160)

0.545

LBR

37.07%(96/259)

41.25%(66/160)

0.603

MR

7.34%(19/259)

6.25%(10/160)

0.695

CCPR

57.14%(232/406)

76.77%(476/620)

 < 0.001

CLBR

43.95%(178/405)

65.80%(406/617)

 < 0.001

Back to article page